V Arienti

Plain English
This study examined how Gamma Knife radiosurgery (a type of targeted radiation therapy) is used to treat brain metastases in a rare skin cancer called Merkel cell carcinoma (MCC). In a specific case, a 75-year-old male patient showed significant reduction in his brain lesions after treatment, with one lesion disappearing completely, and he remained symptom-free for a year. The broader review of 20 patients indicated that radiosurgery was effective, leading to local control of the cancer and improved outcomes, especially when combined with immunotherapy. Who this helps: This benefits patients with Merkel cell carcinoma who have brain metastases, as well as their doctors in determining effective treatment options.

Plain English
This research looked at early-onset psychosis (EOP), which occurs before age 18, and summarized findings from 30 previous studies involving over 25,000 young people. The review found that 60.1% of these individuals had a poor prognosis, and they tended to have more cognitive problems compared to others. Clozapine was found to be the most effective antipsychotic medication for treating symptoms of EOP, although side effects and how well patients tolerate different medications varied. Who this helps: This benefits patients with early-onset psychosis and their doctors, guiding treatment options.

Plain English
This study looked at outpatients who have treatment-resistant depression (TRD) to find out what factors might lead them to attempt suicide. Out of 63 participants, about 33% had attempted suicide, and factors like substance use and having other mental health disorders were strongly linked to this risk. Specifically, patients who abused substances were over six times more likely to attempt suicide compared to those who didn't. Who this helps: This information benefits patients with treatment-resistant depression and their healthcare providers by highlighting the need for comprehensive care.

Plain English
This study looked at young adults who were hospitalized for the first time due to psychosis and aimed to identify factors that could predict whether they would be readmitted within a year. Out of 80 patients studied, 44% were readmitted, and factors such as substance use and being discharged on oral medications increased the likelihood of readmission significantly. The research highlights that using long-acting injection antipsychotics could help reduce the chances of patients returning to the hospital. Who this helps: This helps young patients with psychosis and their doctors in making treatment decisions.

Plain English
This study looked at how adding lurasidone to clozapine treatment helps patients with schizophrenia that doesn’t respond to standard treatments. In four patients, using lurasidone alongside clozapine led to a significant decrease in both positive and negative symptoms of schizophrenia, and there were no major side effects noted. This is important because it offers a new option for improving the condition of patients who are not fully responding to their current treatment. Who this helps: Patients with treatment-resistant schizophrenia.

Plain English
This study looked at a treatment called adaptive staged-dose Gamma Knife radiosurgery for patients with large brain metastases, which are tumors that have spread to the brain from other parts of the body. In a group of 40 patients treated, 75% were still alive after six months, and the treatment was very effective at controlling the tumors, with a 96.7% success rate at that same time. This is important because it shows that this non-invasive treatment can safely help patients with large brain tumors while minimizing side effects. Who this helps: This helps patients with large brain metastases and their doctors in making treatment decisions.

Plain English
This study looked at how two antipsychotic medications, lurasidone and cariprazine, affect cognitive abilities in people with schizophrenia. It found that lurasidone improved cognitive performance more than placebo and other treatments, while cariprazine also showed better cognitive results compared to other medications. These findings are important because they suggest that these drugs might help address cognitive deficits, which are often neglected in schizophrenia treatment. Who this helps: Patients with schizophrenia struggling with cognitive issues.

Plain English
This study looked at the health outcomes of young people at high risk for developing psychosis who did not actually experience it. Researchers analyzed 28 studies involving 2,756 individuals and found that those who did not transition to psychosis showed improvements in symptoms over an average follow-up of about 30 months. Specifically, 48.7% of these individuals improved significantly, but less than half fully recovered by the end of the study. Who this helps: This research benefits patients at risk of psychosis and their healthcare providers by highlighting the need for ongoing support.

Plain English
Researchers studied the effects of a nasal spray called esketamine on a girl who has both autism and severe depression that didn't respond to other treatments. They found that this girl was the first reported case of someone with autism and major depression treated with esketamine, which is important because individuals with autism often struggle to find effective treatments for their depression. This matters because it opens up new possibilities for helping patients with similar conditions who have not benefited from traditional therapies. Who this helps: Patients with autism who also experience treatment-resistant depression.

Plain English
This study looked at a non-cancerous growth called Rathke's cleft cyst, which can cause problems if it keeps coming back after surgery. Researchers used a treatment called stereotactic radiosurgery with Gamma Knife on a patient whose cyst had regrown twice after surgery. Three years later, the patient was symptom-free, with a smaller cyst shown on MRI scans, highlighting that this treatment can successfully reduce the size of the cyst without additional surgery. Who this helps: This benefits patients with recurrent Rathke's cleft cysts.

Plain English
This study looked at a patient who experienced serious mental health issues after using Salvia divinorum, a new psychoactive substance that he didn't realize he was taking. The patient initially did not respond to two different medications but improved significantly when treated with brexiprazole, showing almost complete recovery without major side effects. This finding highlights the potential for brexiprazole to effectively treat psychotic symptoms linked to new substances like Salvia divinorum, which are becoming more common. Who this helps: This helps patients who experience psychotic symptoms from new drugs.

Plain English
This study looked at people who are at high risk for developing psychosis to see how their symptoms and daily functioning change over time. They found that improvements were noticeable in positive symptoms (like hallucinations) after 12 and 24 months, with 33.4% of participants getting better within a year, and 42.4% showing improvement after three years. However, the study also showed that while there are early improvements, these benefits don't last long-term, highlighting the need for ongoing support and treatment for these individuals. Who this helps: This research helps patients at high risk for psychosis and the doctors treating them.

Plain English
This study looked at how likely young people at risk for psychosis (those showing early warning signs) are to actually develop psychosis over time. It found that about 25% of these individuals transition to psychosis within three years, and this risk continues to grow, reaching 35% by ten years. Understanding these risks is crucial for developing better prevention strategies and monitoring for those at high risk. Who this helps: This helps patients at risk for psychosis and the doctors treating them.

Plain English
This study looked at how Gamma Knife radiosurgery was used to treat patients with brain metastases during the COVID-19 pandemic in Italy. Out of 30 patients treated, the approach helped improve symptoms and limited their hospital stays to just a day for most, which freed up resources for COVID-19 patients. This is important because it shows that safe and effective cancer treatment can continue even during public health emergencies, minimizing the impact on healthcare systems. Who this helps: This helps cancer patients who need urgent treatment while the healthcare system is stretched.

Plain English
The study looked at how radiation therapy is used to treat patients with oligometastatic cancer (cancer that has spread to a few areas) among radiation oncologists in Lombardy, Italy. They found that 7% of the nearly 15,700 cancer patients treated with radiation in 2016 had oligometastatic cancer, with most treated using precise methods; in fact, 95% received advanced radiation techniques. This matters because it helps understand the treatment patterns and effectiveness for patients with this specific type of cancer, potentially leading to improved care and collaborative research in this area. Who this helps: Patients with oligometastatic cancer and their doctors.

Plain English
This study looked at the rates of deep vein thrombosis (DVT) in patients who were hospitalized for acute medical issues. Among nearly 1,200 patients who were monitored, only 3 (0.025%) developed DVT during their hospital stay, indicating that DVT occurring in hospitals is very rare. These findings are important because they suggest that current methods of preventing DVT in hospitalized patients may need to be reevaluated, especially since more than 90% of DVT cases were found in patients upon admission rather than developing during their stay. Who this helps: This helps doctors and healthcare providers in making better decisions about DVT prevention for hospitalized patients.

Plain English
This research studied the treatment and outcomes of 151 elderly patients over 65 years old with glioblastoma, a type of brain cancer, at three hospitals in Lombardia, Italy. The findings indicate that patients who underwent extensive surgery and received radiotherapy and chemotherapy had better survival rates, with significant improvements in outcomes linked to these treatments (patients receiving radiotherapy had a 80% lower risk of death). This matters because it helps refine treatment approaches for older patients, potentially leading to longer survival times. Who this helps: This helps doctors and older patients diagnosed with glioblastoma.

Plain English
This study focused on using bedside ultrasound to diagnose acute cholecystitis (AC), a common and serious condition that occurs when the gallbladder becomes inflamed. Researchers found that when gallstones are present and there is pain in the abdomen, using a specific ultrasound technique can correctly identify AC 92.2% of the time. This is important because quick and accurate diagnosis can improve treatment and outcomes for patients with this painful condition. Who this helps: Patients suspected of having acute cholecystitis.

Plain English
This study looked at how well a technique called sonoelastography can identify different types of liver tumors. Researchers tested this method on 43 patients with 38 liver lesions and found that it could accurately distinguish between benign (non-cancerous) and malignant (cancerous) lesions. Specifically, they noted that benign lesions had a lower strain ratio and hardness percentage compared to malignant ones, with a strong accuracy (with scores around 0.88 to 0.89 for diagnostic performance). Who this helps: This benefits doctors and patients by providing a reliable way to assess liver lesions without invasive procedures.

Plain English
This study looked at how using small ultrasound machines in hospitals can benefit internal medicine by acting like a modern stethoscope. It found that using these devices helps doctors quickly and accurately diagnose conditions such as neck nodules, breathing issues, abdominal pain, and swelling in the limbs. Since 2005, training programs have been established to teach doctors how to effectively use this technology, improving patient care through faster diagnoses. Who this helps: This helps patients and doctors in internal medicine departments.

Plain English
This study looked at using abdominal ultrasound to diagnose non-alcoholic fatty liver disease (NAFLD) and early signs of vascular damage in people, particularly focusing on its role in identifying metabolic syndrome. Researchers found that ultrasound is a reliable and effective method for diagnosing NAFLD and early vascular issues, which is crucial because untreated NAFLD can progress to more serious liver diseases. This matters because early detection can help prevent severe health problems like liver cirrhosis and cancer. Who this helps: This benefits patients at risk for metabolic syndrome and liver diseases, allowing for earlier intervention and better health outcomes.

Plain English
This study looked at how bedside ultrasonography (US) is used in Internal Medicine and Emergency Departments to help diagnose and treat patients quickly. The research found that using US can significantly speed up treatment and lower the chances of complications from invasive procedures, making it a safer option for patients. This approach is useful across various skill levels among healthcare providers, ensuring that even those with basic training can effectively use US. Who this helps: Patients in emergency and internal medicine settings benefit the most from this technology.

Plain English
This study looked at the long-term outcomes of 432 patients with liver cirrhosis and early-stage liver cancer, treated with a method called ultrasound-guided percutaneous laser ablation (PLA). The researchers found that 78% of patients responded completely to the treatment, with an average survival time of 47 months; even better, patients with smaller tumors under 2 cm had a 60% chance of surviving five years. These findings highlight that complete tumor removal through PLA can significantly improve survival, particularly for younger patients with good liver function and small tumors. Who this helps: This helps patients with early liver cancer and their doctors in choosing effective treatment options.

Plain English
This study looked at whether patients with nonalcoholic fatty liver disease (NAFLD) have more issues with their carotid arteries compared to those without the condition. Among 154 outpatients, those with NAFLD had a thicker carotid artery wall (0.84 mm) compared to non-NAFLD patients (0.71 mm), and 57.8% of those with NAFLD also had carotid plaques, compared to 37.5% of those without NAFLD. These findings are important because they indicate that liver fat buildup may hint at a higher risk for serious heart problems that can go unnoticed. Who this helps: This helps patients with nonalcoholic fatty liver disease and their doctors by highlighting the need for monitoring cardiovascular health.

Plain English
This research looked at the complications that can occur after laser treatment for liver cancer, specifically hepatocellular carcinoma (HCC), in 520 patients from nine hospitals in Italy. They found that serious complications happened in only 1.5% of the treatments, with a low death rate of 0.8%. The study also showed that the treatment was most effective for smaller tumors, achieving complete destruction in 81% of cases for tumors under 3 cm in size, which is important because it indicates that laser ablation can be a safe and effective option for treating small liver cancers. Who this helps: Patients with small liver tumors.

Plain English
This study looked at how different methods of radiotherapy affect the appearance of the breast and the success of treating early breast cancer in 1,176 patients who had conservative surgery. It found that after five years, the cancer control rates were very high—98% locally and 99% regionally. However, less advanced radiation techniques tended to result in poorer cosmetic outcomes. Who this helps: This benefits breast cancer patients receiving radiation therapy after surgery.

Plain English
This study looked at how different body positions (standing or lying down) affect blood flow in patients with pre-ascitic cirrhosis compared to healthy individuals. The researchers found that both groups showed similar blood flow patterns when standing, but patients had lower heart performance indicators after receiving additional fluid; for instance, healthy subjects showed a cardiac index (CI) of 5.1 liters/minute compared to 3.9 in patients. The findings highlight that the management of blood volume is vital for improving circulation in these patients, especially since their blood flow changes significantly depending on their posture. Who this helps: This helps patients with pre-ascitic cirrhosis and their doctors in understanding how to manage their condition better.

Plain English
This study looked at how well doctors in Lombardy, Italy, followed treatment guidelines for early breast cancer from 1997. Out of 1,547 women studied, 33% received only chemotherapy, another 33% received only hormonal therapy, and 29% got no adjuvant treatment at all, which was not in line with established guidelines. The findings indicate that many patients, especially those at intermediate to high risk, did not receive the appropriate treatments, highlighting gaps in care despite clear guidelines. Who this helps: This information benefits doctors and healthcare providers working with breast cancer patients.

Plain English
This study looked at how interferon therapy affects patients with cirrhosis caused by hepatitis C virus. Out of 72 patients who received interferon treatment, 6 developed liver cancer, compared to 19 out of 72 patients who did not receive treatment, showing that interferon may help prevent liver cancer. However, overall survival rates and the likelihood of experiencing other complications were similar between both groups. Who this helps: This research benefits patients with hepatitis C-related cirrhosis and their doctors by highlighting the importance of treatment to prevent liver cancer.

Plain English
This study looked at how different factors affect survival in 49 adults with low-grade brain tumors called astrocytomas after they had surgery and radiation therapy. The researchers found that younger patients with tumors that were completely removed tended to live longer, while specific factors like the patient's overall health and the location of the tumor also played a significant role in their survival chances. Understanding these factors helps doctors find better ways to treat these tumors and improve patient outcomes. Who this helps: Patients with low-grade astrocytomas and their doctors.

Plain English
This study looked at how well thymosin alpha 1 works for treating chronic hepatitis C in 19 Italian patients. After six months of treatment, only one patient taking thymosin alpha 1 showed improved liver enzyme levels, but they relapsed within six months, and overall, there was no significant improvement in any patient’s condition. This is important because it shows that thymosin alpha 1 is not an effective treatment for chronic hepatitis C, guiding doctors towards better options for their patients. Who this helps: This helps doctors and patients seeking effective treatments for chronic hepatitis C.

Plain English
This study looked at blood flow in the stomach area of people with celiac disease, comparing those who weren't treated to those who were and to healthy individuals. Researchers found that untreated patients had faster blood flow in a key artery compared to those who were treated or healthy, with significant improvements after nine months on a gluten-free diet. Understanding these changes in blood flow is important because it shows how treatment can impact the health of patients with celiac disease. Who this helps: This helps patients with celiac disease and their doctors.

Plain English
Researchers tested whether ultrasound could accurately measure how much of the colon was damaged and how severe the inflammation was in 57 patients with ulcerative colitis (a serious bowel disease). The ultrasound was highly accurate—correctly identifying the extent and severity of disease 91-93% of the time when compared to other imaging methods and surgical findings. After patients received intensive treatment for 10 days, ultrasound showed significant improvement in their inflammation, proving the technology could track whether medications were actually working. This matters because ultrasound is fast, safe, and non-invasive, giving doctors a practical tool to measure disease severity, decide on treatment, and objectively confirm that treatment is helping—without exposing patients to radiation or surgery.

Plain English
This study looked at how effective two targeted treatments, transcatheter arterial chemoembolization (TACE) and intraarterial chemotherapy (IAC), are for survival in patients with advanced liver cancer (hepatocellular carcinoma, HCC). It involved 164 patients, where those receiving TACE had a much better survival rate (30% alive after four years) compared to those who only received IAC (0% alive after four years) and those who received no treatment at all. This matters because it shows that TACE is a more effective treatment option for patients who cannot have surgery, helping them live longer. Who this helps: This benefits patients with advanced liver cancer who are not candidates for surgery.

Plain English
This study looked at how a surgical procedure called distal splenorenal shunt affects blood levels of certain amino acids and ammonia in 10 patients with liver cirrhosis over one year. After the surgery, patients showed increased levels of amino acids like tyrosine and ammonia, while some others were reduced. Although these changes in the body's chemistry can be concerning, the patients didn't experience worsened brain symptoms from eating protein-rich foods, which is good news for managing their condition. Who this helps: This helps patients with liver cirrhosis and healthcare providers managing their treatment.

Plain English
In this study, researchers looked at how a single dose of erythromycin, an antibiotic, affects how quickly food leaves the stomach and gallbladder. They found that a 500 mg dose of erythromycin made both the stomach and gallbladder empty faster compared to when no medication was given. This is important because faster emptying can help improve digestion and could benefit treatments for certain gastrointestinal issues. Who this helps: This helps patients with digestive concerns.

Plain English
This study looked at how the medication levosulpiride affects stomach and gallbladder emptying in people with functional dyspepsia, a condition that often causes discomfort and delayed digestion. Researchers treated 30 patients with either levosulpiride or a placebo for 20 days, finding that those who took levosulpiride experienced faster stomach emptying times and a reduction in symptoms like bloating and pain. Specifically, gastric emptying was faster by a significant margin at different time points, improving overall patient comfort. Who this helps: This benefits patients suffering from functional dyspepsia seeking relief from their symptoms.

Plain English
This study looked at different types of liver cancer in 416 Italian patients, examining how factors like age, gender, blood type, alcohol consumption, and smoking impacted the types of cancer. They found that most cases were solitary tumors (54.8%), while multinodular tumors were present in 31%, and other types were less common. The study also revealed that having cirrhosis or a non-O blood type increased the risk of multinodular tumors, while heavy smoking and a lack of cirrhosis raised the risk of massive tumors. Who this helps: This research benefits doctors and patients by providing insights into liver cancer risk factors and tumor types.

Plain English
This study looked at the effects of a surgical procedure called distal splenorenal shunt (DSRS) on hormone levels and blood sugar control in patients with liver cirrhosis. Researchers found that after the surgery, patients had higher levels of glucagon (increased from about 181 to 255 pg/ml) and ammonia, while the effectiveness of glucagon decreased over the year. This is important because it shows the surgical procedure changes certain hormone levels without harming liver function, which could impact how these patients manage their blood sugar. Who this helps: This helps patients with cirrhosis who may undergo this surgical procedure.

Plain English
This study looked at two imaging methods—indium-111 scans and ultrasound—to see which one better assesses the location and inflammation of lesions in patients with Crohn's disease. It found that ultrasound was 77% effective at identifying lesions compared to the indium-111 scan, which was 69.2% effective. Ultrasound also provided similar insights into how active the disease was and is a cheaper and less harmful option, making it a valuable tool in managing Crohn's disease. Who this helps: Patients with Crohn's disease and their doctors.

Plain English
This study looked at how effective a specific type of radiation therapy, called definitive transcutaneous radiotherapy, is for treating oropharyngeal cancer in 199 patients from 1976 to 1986. The researchers found that 56% of the patients died from their cancer within five years, and 75% experienced some form of local progression or recurrence of the disease, mostly within two years after treatment. The results show that the stage of cancer at the start (T and N categories) heavily influenced survival rates and that aggressive treatment can lead to better local control of the tumor. Who this helps: This information benefits patients with oropharyngeal cancer and their doctors by highlighting the importance of cancer staging and treatment intensity.

Plain English
This study looked at 135 Italian patients with liver cancer (hepatocellular carcinoma) to understand how different health indicators affect survival. On average, patients survived for 12 months after diagnosis, and factors like having no treatment, severe symptoms, and advanced cancer stage significantly reduced survival chances. This research is important because it helps doctors identify patients who are more likely to survive and can benefit from treatment options. Who this helps: Patients with liver cancer and their doctors.